An Open-label Study of the Safety and Pharmacokinetics of the TGKP

Conditions: Acute Respiratory Distress Syndrome (ARDS) Interventions: Drug: Glycolic acid tetrasubstituted piceatannol (TGKP) Sponsors: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting

https://clinicaltrials.gov/study/NCT06127381

Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials